Dogwood Therapeutics, Inc.
DWTX
$6.21
-$0.01-0.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.74M | -3.81M | -10.93M | -7.73M | -2.28M |
| Total Depreciation and Amortization | 17.30K | 17.30K | 17.00K | 12.20K | -- |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 52.40K | 58.40K | -- |
| Total Other Non-Cash Items | 12.09M | 60.00K | 6.42M | 3.69M | 94.30K |
| Change in Net Operating Assets | 361.70K | -296.00K | -243.00K | -2.16M | 1.28M |
| Cash from Operations | -3.27M | -4.03M | -4.68M | -6.13M | -910.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 3.76M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 3.76M | -- |
| Total Debt Issued | 0.00 | 0.00 | 3.00M | 15.32M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | -- | 4.37M | 0.00 | -- |
| Repurchase of Common Stock | -- | -120.10K | -- | -400.00 | -70.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | -120.10K | 7.37M | 15.32M | -70.20K |
| Foreign Exchange rate Adjustments | -3.30K | 10.10K | 1.20K | -144.60K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.28M | -4.14M | 2.69M | 12.81M | -980.40K |